Loading...
Coya Therapeutics Inc (COYA) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of significant positive catalysts, weak financial performance, and absence of strong trading signals suggest holding off on this investment for now.
The MACD is positive and expanding, indicating a slight bullish momentum. RSI is neutral at 60.812, and moving averages are converging, showing no clear trend. Support and resistance levels are at S1: 4.579 and R1: 5.029, suggesting limited price movement.

NULL identified. No recent news or significant insider or hedge fund activity.
Weak financial performance with a YoY decline in net income (-47.39%) and EPS (-50.00%). No recent congress trading data or influential figure activity.
In Q3 2025, revenue remained flat YoY at $3,564,254. Net income dropped significantly by -47.39% YoY to -$2,115,831, and EPS fell by -50.00% YoY to -$0.13. Gross margin remained at 100%, but overall financials show a lack of growth.
No data available for analyst ratings or price target changes.